ARIPIPRAZOLE ACCORD 30mg tablets
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Find medicines for human use by name or active substance.
Browse by initial
1,561–1,580 of 2,168 medicines
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: aripiprazole
N05AX12 Nervous system | Antipsychotics | Other antipsychotics
Indicated for: schizophrenia; bipolar disorder
Active substance: ciprofloxacin
J01MA02 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: duloxetine
N06AX21 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression; neuropathic pain
Active substance: duloxetine
N06AX21 Nervous system | Antidepressants | Other antidepressants
Indicated for: depression; neuropathic pain
Active substance: fondaparinux sodium
Indicated for: prevention and treatment of thromboembolism
Active substance: fondaparinux sodium
Indicated for: prevention and treatment of thromboembolism
Active substance: fondaparinux sodium
Indicated for: prevention and treatment of thromboembolism
Active substance: fondaparinux sodium
Indicated for: prevention and treatment of thromboembolism
Active substance: fondaparinux sodium
Indicated for: prevention and treatment of thromboembolism
Active substance: paroxetine
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression; anxiety disorders
Active substance: paroxetine
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression; anxiety disorders
Active substance: paroxetine
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression; anxiety disorders
Active substance: paroxetine
N06AB05 Nervous system | Antidepressants | Selective serotonin reuptake inhibitors
Indicated for: depression; anxiety disorders
Active substance: cinnarizine + dimenhydrinate
N07CA52 Nervous system | Antivertigo preparations
Indicated for: vertigo; vestibular disorders
Active substance: cinnarizine + dimenhydrinate
N07CA52 Nervous system | Antivertigo preparations
Indicated for: vertigo; vestibular disorders
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.